Tumor PIK3CA Genotype and Prognosis in Early-Stage Breast Cancer: A Pooled Analysis of Individual Patient Data

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Dimitrios ZardavasSherene Loi

Abstract

Purpose Phosphatidylinositol-4, 5-bisphosphate 3-kinase catalytic subunit alpha ( PIK3CA) mutations are frequently observed in primary breast cancer. We evaluated their prognostic relevance by performing a pooled analysis of individual patient data. Patients and Methods Associations between PIK3CA status and clinicopathologic characteristics were tested by applying Cox regression models adjusted for age, tumor size, nodes, grade, estrogen receptor (ER) status, human epidermal growth factor receptor 2 (HER2) status, treatment, and study. Invasive disease-free survival (IDFS) was the primary end point; distant disease-free survival (DDFS) and overall survival (OS) were also assessed, overall and by breast cancer subtypes. Results Data from 10,319 patients from 19 studies were included (median OS follow-up, 6.9 years); 1,787 patients (17%) received chemotherapy, 4,036 (39%) received endocrine monotherapy, 3,583 (35%) received both, and 913 (9%) received none or their treatment was unknown. PIK3CA mutations occurred in 32% of patients, with significant associations with ER positivity, increasing age, lower grade, and smaller size (all P < .001). Prevalence of PIK3CA mutations was 18%, 22%, and 37% in the ER-negative/HER2-negative, ...Continue Reading

References

Jan 14, 2005·Proceedings of the National Academy of Sciences of the United States of America·Sohye KangPeter K Vogt
Jun 14, 2005·Cancer Cell·Yardena SamuelsVictor E Velculescu
Dec 1, 2005·Breast Cancer Research and Treatment·Shao Ying LiBarry Iacopetta
Dec 3, 2005·Cancer Research·Steven J IsakoffJoan S Brugge
Dec 13, 2005·Proceedings of the National Academy of Sciences of the United States of America·Jean J ZhaoThomas M Roberts
Jul 19, 2006·Nature Reviews. Genetics·Jeffrey A EngelmanLewis C Cantley
Jan 5, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Naomi MaruyamaShinzaburo Noguchi
May 22, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Clifford A HudisJo Anne Zujewski
Jun 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gizeh Pérez-TenorioOlle Stål
Oct 20, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mattia BarbareschiAntonio Marchetti
Feb 13, 2008·Proceedings of the National Academy of Sciences of the United States of America·Li Zhao, Peter K Vogt
Aug 5, 2008·Cancer Research·Katherine Stemke-HaleBryan T Hennessy
Feb 24, 2009·Biochemical and Biophysical Research Communications·Claire ChaussadePeter R Shepherd
Apr 8, 2009·The American Journal of Pathology·Kuan-Ting KuoIe-Ming Shih
Jul 28, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Y KataokaH Minami
Aug 13, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kevin KalinskyMary Ellen Moynahan
Aug 18, 2009·International Journal of Cancer. Journal International Du Cancer·Elena López-KnowlesRobert L Sutherland
Dec 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mitch DowsettRichard Peto
May 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Sherene LoiChristos Sotiriou
Jun 17, 2010·Cancer Research·Alexander MironKornelia Polyak
Oct 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Todd W MillerCarlos L Arteaga
Dec 17, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J D JensenM Ewertz
Feb 15, 2012·Breast Cancer Research : BCR·Magdalena CizkovaIvan Bièche
Jun 23, 2012·Nature·Shantanu BanerjiMatthew Meyerson
Sep 25, 2012·Nature·UNKNOWN Cancer Genome Atlas Network
Jun 7, 2013·Journal of the National Cancer Institute·Sherene LoiChristos Sotiriou
May 16, 2014·Endocrine-related Cancer·Hatem A AzimChristos Sotiriou
Jun 3, 2014·The New England Journal of Medicine·Olivia PaganiUNKNOWN International Breast Cancer Study Group
Jul 30, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vicky S SabineJohn M S Bartlett
Sep 6, 2014·Breast Cancer Research : BCR·Dimitrios ZardavasSherene Loi
Aug 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J D JensenM Ewertz

❮ Previous
Next ❯

Citations

Mar 8, 2019·Endocrine-related Cancer·Marie Colombe AgahozoCarolien van Deurzen
Dec 21, 2019·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N VasanM Scaltriti
Mar 27, 2020·Medical Sciences : Open Access Journal·Ugo TestaElvira Pelosi
Feb 6, 2020·Breast Cancer Research and Treatment·Tomoko ShibayamaShunji Takahashi
Jul 3, 2020·Breast Cancer Research and Treatment·Diana G WangMario E Lacouture
May 8, 2020·Analytical Cellular Pathology (Amsterdam)·Didier MeseureIvan Bieche
Sep 10, 2019·Expert Review of Molecular Diagnostics·Karthik V Giridhar, Minetta C Liu
Sep 15, 2020·EMBO Molecular Medicine·Christian BruefferLao H Saal
Sep 15, 2020·Current Opinion in Oncology·Sonia Pernas, Sara M Tolaney
Dec 7, 2018·Molecular Cancer Therapeutics·Shuying LiuAna M Gonzalez-Angulo
Aug 28, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Valentina GuarneriPierfranco Conte
Feb 7, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ingrid A MayerCarlos L Arteaga
Oct 22, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Elena Guerini-RoccoMarco Colleoni
Dec 31, 2020·International Journal of Molecular Sciences·Daniela MiricescuMaria Greabu
Feb 19, 2020·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F MoseleF André
Nov 7, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Lin WangZhaohui Lyu
Mar 13, 2021·Therapeutics and Clinical Risk Management·Dwan-Ying ChangYen-Shen Lu
Mar 17, 2021·British Journal of Cancer·Albert Gris-OliverVioleta Serra
Apr 3, 2021·Communications Biology·Satoi NagasawaYutaka Suzuki
Jan 6, 2021·International Journal of Surgery Case Reports·Sarah BouriJean-Christophe Noël
May 27, 2021·Nature Communications·Samuel J RodgersChristina A Mitchell
Jun 11, 2021·JCO Oncology Practice·Sonia Pernas, Sara M Tolaney
Jun 21, 2021·Seminars in Cancer Biology·Zhan HuaJianjun Zhou
Jul 25, 2021·Cancers·Huayi LiFederico Gulluni
Aug 11, 2021·Surgical Pathology Clinics·Dara S Ross, Fresia Pareja
Sep 26, 2021·NPJ Breast Cancer·Cynthia Villarreal-GarzaHatem A Azim

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.